Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the University of Chicago takes a different approach, centered on preserving insulin-producing beta cells by giving them the ability to protect themselves.
Nanoparticle system shows promise for delivering mRNA to prevent type 1 diabetes
